Flu Vaccine Shortage Alert
Oct 5, 2004 -- The US. faces a significant shortage in flu vaccine. This became evident today after Chiron Corp., manufacturer of the influenza vaccine Fluvirin, announced it is unable to release flu vaccine for at least 3 months. Fluvirin, which is manufactured in England, accounts for almost half of the total US influenza vaccine supply.
It has been recommended that the available flu vaccine be reserved for the following high-risk groups, which are considered of equal priority:
These guidelines have been jointly agreed upon by the CDC (Centers for Disease Control and Prevention), the AAP (American Academy of Pediatrics), and the AAFP (American Academy of Family Physicians).
The inhaled flu vaccine FluMist is appropriate for healthy people 5-49 years of age in close contact with infants 0-6 months of age and for health care workers who are not in contact with severely immunocompromised persons.
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions